Retrospective Study
Copyright ©The Author(s) 2024.
World J Crit Care Med. Sep 9, 2024; 13(3): 92658
Published online Sep 9, 2024. doi: 10.5492/wjccm.v13.i3.92658
Table 2 Laboratory test measurements among the studied population
Variable
All patients, n = 53
Narrow-spectrum antibiotics, n = 12
Broad-spectrum antibiotics, n = 41
P value
Creatinine in micromole/L95.0 (72.0-110) (N = 51) 79.0 (ΔIQR 24.0) (n = 11)95.0 (ΔIQR 46.0) (n = 40)0.688
Highest creatinine in micromole/L110 (85.0-175) (N = 51)95.0 (ΔIQR 29.0) (n = 11)107.5 (ΔIQR 106) (n = 40)0.457
Bilirubin in micromole/L9.0 (6.9-17.1) (N = 47)8.6 (ΔIQR 26.5) (n = 10)9.5 (ΔIQR 6.7) (n = 37)0.755
SGPT in U/L26.0 (18.0-40.0) (N = 47)18.0 (ΔIQR 13.5) (n = 9)25.5 (ΔIQR 22.3) (n = 38)0.185
HbA1c as %6.3 ± 1.65.9 ± 1.76.3 ± 1.50.243
Hb in mg/dL12.9 ± 2.0 (N = 52)13.2 ± 1.9 (n = 12)12.7 ± 2.0 (n = 40)0.239
WBC as 103/U10.8 ± 5.2 (N = 49)6.8 (ΔIQR 4.0) (n = 10)8.8 (ΔIQR 3.0) (n = 39)0.076